Currently, Recursion Pharmaceuticals Inc’s (RXRX) stock is trading at $7.04, marking a fall of -0.13% from last night’s close. At this price, the stock is -57.95% below its 52-week high of $16.75 and 55.08% above its 52-week low of $4.54. Based on the past 30-day period, the stock price is -8.43% below the high and +43.16% above the low.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, RXRX’s SMA-200 is $7.93.

As well, it is important to consider RXRX stock ratios such as price-to-sales, which is currently 32.09.RXRX’s price to book ratio for the most recent quarter was 3.47, resulting in an 3.90 price to cash per share for the period.

How does Recursion Pharmaceuticals Inc (RXRX) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 7 brokerage firms that recommend the stock as a Moderate Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 3.71 in simple terms.

Recursion Pharmaceuticals Inc (RXRX): Earnings History

Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 5 different analysts, who are expecting earnings to fall in between the range of -0.30 and -0.53 with an average Earnings Estimate of -0.45 which is in contrast with the last year earnings estimate of -0.31 and also replicates -45.16% growth rate year over year.

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Ownership Details

I will give a breakdown of the key shareholders in Recursion Pharmaceuticals Inc (RXRX). Recent figures show that the company’s insiders hold 6.80% of shares. A total of 235 institutional investors hold shares in the company, making 88.93% of its stock and 95.41% of its float.

Jun 29, 2023, it was reported that the Company’s largest institutional holder is Baillie Gifford and Company holding total of 25.1 million shares that make 12.30% of the company’s total number of shares and are currently priced at 187.48 million.

The securities firm Blackrock Inc. holds 11.62 million shares of RXRX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 5.69%, and the holding percentage of shares is valued at 86.8 million.

An overview of Recursion Pharmaceuticals Inc’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Recursion Pharmaceuticals Inc (RXRX) traded 4,311,461 shares per day, with a moving average of $5.88 and price change of +1.41. With the moving average of $6.75 and a price change of -1.22, about 3,667,205 shares changed hands on average over the past 50 days. Finally, RXRX’s 100-day average volume is 5,488,319 shares, alongside a moving average of $8.60 and a price change of -0.27.

Leave a Reply

Your email address will not be published. Required fields are marked *